The trial results represent one of the strongest demonstrations yet of AI diagnostic systems outperforming trained specialists in early-stage cancer detection.
Trial Details
The trial screened over 50,000 patients across the 12 participating hospitals, with the AI system flagging early-stage cancers that were initially missed by standard screening protocols in nearly 15% of cases.
Regulators say the results support an accelerated review pathway for wider clinical deployment within the next year.
#Health#AIDiagnostics
